INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
2.210
+0.040 (1.84%)
May 20, 2025, 9:50 AM - Market open

INVO Fertility Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Revenue
6.53-
Cost of Revenue
3.66-
Gross Profit
2.87-
Selling, General & Admin
9.082.16
Research & Development
0.490.98
Operating Expenses
10.493.13
Operating Income
-7.61-3.13
Interest Expense
-1.06-0.14
Other Non Operating Income (Expenses)
0.09-
EBT Excluding Unusual Items
-8.58-3.28
Gain (Loss) on Sale of Investments
0.01-
Gain (Loss) on Sale of Assets
-0.51-
Other Unusual Items
-0.04-
Pretax Income
-9.12-3.28
Income Tax Expense
-0.02-
Net Income
-9.1-3.28
Net Income to Common
-9.1-3.28
Shares Outstanding (Basic)
00
Shares Outstanding (Diluted)
00
Shares Change (YoY)
44.89%-
EPS (Basic)
-29.39-15.35
EPS (Diluted)
-30.19-15.36
Free Cash Flow
-3.16-
Free Cash Flow Per Share
-10.20-
Gross Margin
44.00%-
Operating Margin
-116.56%-
Profit Margin
-139.25%-
Free Cash Flow Margin
-48.35%-
EBITDA
-6.69-
EBITDA Margin
-102.48%-
D&A For EBITDA
0.92-
EBIT
-7.61-3.13
EBIT Margin
-116.56%-
Revenue as Reported
6.53-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.